View this as a webpage
Minnesota Department of Health
Dec. 2, 2021
Good afternoon,
Here are the COVID-19 vaccine provider updates for Nov. 24 to Dec. 2, 2021.
On Nov. 29, 2021, CDC recommended that all people 18 years and older should get a booster dose of COVID-19 vaccine. There is no longer a need to determine if a person is in a risk group; give them a booster if it has been 6 months since completing the mRNA (Pfizer or Moderna) series, or 2 months since receiving the Janssen (Johnson & Johnson) initial dose. Any of the products can be given without regard to what product a person originally received.
Prioritize your capacity to serve groups that would most benefit from a booster dose. This includes people 50 years and older, those living in long-term care facilities, and people that received the Janssen vaccine.
Refer to CDC’s media statement: CDC Expands COVID-19 Booster Recommendations and the Interim Clinical Considerations for Use of COVID-19 Vaccines for details.
Appendices A-C have been updated with the latest booster dose recommendations in the “Vaccine recommendations” section for each appendix. Find them at COVID-19 Vaccine Providers.
In accordance with the booster recommendation change described above, MIIC now forecasts a booster dose for clients age 18 years and older who have received two doses of an mRNA COVID-19 vaccine (Comirnaty/Pfizer or Spikevax/Moderna). Of note, the forecaster was updated in October 2021 to forecast a booster for Janssen vaccine recipients, so MIIC now forecasts a booster for all fully vaccinated people 18 years and older. The recommended date for the mRNA COVID-19 vaccines will be six months after the date of the second dose. If you have any questions regarding the forecaster in MIIC, please contact the MIIC Help Desk at health.miichelp@state.mn.us.
Continue to reach out to those who are pregnant, recently pregnant, trying to become pregnant, or might become pregnant in the future to recommend and provide COVID-19 vaccines and boosters. Recent studies emphasize the known risks of COVID-19 illness during pregnancy, including increased risk associated with the spread of the Delta variant. Read more in the following articles:
Pfizer U.S. Medical Affairs is hosting “Medical Updates” for its COVID-19 vaccines with a special focus on the vaccine for 5- to 11-year-olds. Training topics for both vaccines (vaccine for 5- to 11-year-olds and 12 years and older) include FDA indication & authorization, CDC/ACIP recommendations, packaging/presentation, storage and handling, and a question and answer session.
Each session will be unique and will reflect any new information or changes that emerge. To access current and future training sessions, please visit Pfizer: Medical Updates & Immunization Site Training for All Healthcare Providers led by Pfizer Vaccines US Medical Affairs.
|